—
The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period. North America accounted for the largest share of the biomarker technologies market. Asia Pacific is expected to register the highest growth from 2017 to 2022 for the biomarker technologies market.Major players in Biomarker Technologies market are identified through secondary research & their market revenues determined through primary and secondary research. The biomarker technologies market is classified into consumables, instruments, services, and software/informatics. The consumables market is further segmented into reagents & kits and chromatography columns.
Download Free PDF Brochure of Biomaker Technologies Market Report Now at
http://www.rnrmarketresearch.com/contacts/request-sample?rname=1509114 .
The biomarker technologies market is highly competitive. The major players in this market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US). Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research.
Objectives of the Study
• To define, describe, and forecast the biomarker technologies market by test type, product, application, profiling technology, disease indication, system, and research type
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and to provide details of the competitive landscape for market leaders
• To forecast the size of the market in North America, Europe, Asia Pacific, and Rest of the World
In 2018, the ELISA segment accounted for the largest share of the immunoassay market. ELISA can simultaneously quantify levels of multiple proteins and have the potential to accelerate the validation of protein biomarkers for clinical use. Such factors are increasing the use of ELISA for confirmatory studies in biomarker discovery. Percentage splits, shares, & breakdowns of segments were determined using secondary sources and verified through primary sources. Top-down & bottom-up approaches were used to validate size of biomarker technologies market and estimate size of various other dependent submarkets.
Get Discount at on Biomarker Technology Market Report Now at
http://www.rnrmarketresearch.com/contacts/discount?rname=1509114 .
Immunoassays held the largest share of the biomarker technologies market, by profiling technology, in 2017. Based on profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share of the market.
#Table of Content
1 Biomarker Technologies Market: Introduction
2 Biomarker Technologies Market: Research Methodology
3 Biomarker Technologies Market, By Test Type
4 Biomarkers Liquid Biopsy Market, By Application
5 Liquid Biopsy Market, By Technology
6 Biomarker Technologies Market, By Product
7 Biomarker Product Market, By Application
8 Biomarker Technologies Market, By Profiling Technology
9 Biomarker Profiling Technology Market, By Application
10 Biomarker Disease Indication Market, By Application
11 Biomarker Technologies Market, By Application
12 Biomarker Technology Applications Market, By Product
13 Biomarker Technologies Market, By Research Area
14 Market Share Analysis
15 Biomarker Technologies Market, By Region
Top-down and bottom-up approaches were used to validate the size of the biomarker technologies market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with key opinion leaders such as CEOs, Directors, and Marketing Executives.
Download Complete Report on “Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022” at http://www.rnrmarketresearch.com/contacts/purchase?rname=1509114 .
In this report, the biomarker technologies market is segmented by test type, product, application, profiling technology, disease indication, system, and research type. Specific segments have also been studied based on application—clinical diagnostics, drug discovery & development, and applied research. The biomarker systems market has also been classified based on products used.
Key Target Audience
• Hospitals and clinics
• Research institutes and clinical research organizations
• Market research and consulting firms
• Authorities framing reimbursement policies for the use of cancer diagnostics
• Companies offering kits/assays/platforms/technologies for biomarker testing
• Pharmaceutical Companies
The biomarker technologies market is classified into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer accounted for the largest share of the biomarker technologies market, as biomarkers have major applications in cancer research, diagnostics, and treatment.
Contact Info:
Name: Snehal
Email: Send Email
Organization: RnRMarketResearch
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Website: http://www.rnrmarketresearch.com/biomarker-technologies-market-by-profiling-technology-chromatography-ngs-pcr-mass-spectrometry-immunoassay-liquid-biopsy-ddpcr-dhplc-research-area-proteomics-lipidomics-application-biomarker-validati-st-to-2022-market-report.html
Release ID: 482152
Google
RSS